57
Participants
Start Date
January 29, 2021
Primary Completion Date
December 13, 2021
Study Completion Date
January 28, 2022
Liquid Alpha1-Proteinase Inhibitor (Human)
Intravenous infusion 120 mg/kg
Placebo
Intravenous infusion
Standard Medical Treatment
SMT
Columbia University Medical Center, New York
University of Miami Hospital, Miami
Birmingham VA, Birmingham
Memphis VA, Memphis
Sparrow Hospital, Lansing
Hannibal Clinic, Hannibal
Kansas City VA, Kansas City
Unidad Medica para la Salud Integral, San Nicolás de los Garza
CHI Health Center, Omaha
University of Utah, Salt Lake City
St. Joseph's Hospital, Phoenix
Hospital Carlos Van Buren, Valparaíso
Hospital Padre Hurtado, Santiago
AngioCor Blumenau, Blumenau
Sociedade Literaria e Caritativa Santo Agostinho, Criciúma
Universidade Estadual São Paulo - Campus de Botucatu, Botucatu
Hospital Dia do Pulmão, Blumenau
Hospital Alemao Oswaldo Cruz, São Paulo
Universidade Federal de Sao Paulo, São Paulo
Fundación Oftalmológica de Santander, Bucaramanga
Lead Sponsor
Grifols Therapeutics LLC
INDUSTRY